JUNS

1.23515.41%
NH

Nicholas H. Hemmerly

Director

Mr. Nicholas H. Hemmerly was Co-Head of Investment Banking of Clear Street Group Inc. until 2026. Mr. Hemmerly was Co-Head of Investment Banking of Clear Street LLC from August 2025 to 2026. He serves as Director at Liberty Star Uranium & Metals Corp. since September 26, 2022. Mr. Hemmerly serves as a Co-Head of Investment Banking at Summit Securities Group LLC (formerly known as Clear Street Markets LLC) since July 2023. He is Chief Financial Officer, Treasurer and Secretary at Sparta Healthcare Acquisition Corp. He has been Independent Director at Jupiter Neurosciences, Inc. (formerly Jupiter Orphan Therapeutics, Inc.) since September 8, 2021. He was a Managing Partner and Head of Investment Banking for Bridgeway Capital Partners LLC, since February 2020. Mr. Hemmerly has investment banking experience with broad transactional experience. Prior to joining Bridgeway from March 2016 to February 2020, Mr. Hemmerly was the Director, Head of Life Sciences Investment banking at PricewaterhouseCoopers Corporate Finance LLC, where he led U.S. M&A and capital raising in the life sciences space with a focus on specialty and generic pharmaceuticals as well as healthcare consumer products and contract manufacturing. Prior to PwC from June 2014 to March 2016, Mr. Hemmerly was a Vice President at Jefferies LLC with a focus on executing M&A and financing transactions within the pharmaceutical and life sciences sectors. Prior experience includes investment banking roles in JPMorgan Chase & Co.'s Healthcare Group as well as JMP Securities LLC's Healthcare Group. Mr. Hemmerly began his investment banking career as an analyst with Wachovia Securities. During his career, Mr. Hemmerly has completed over six billion dollars in M&A and capital raising transactions. Mr. Hemmerly graduated with honors from the College of Charleston with a B.S. degree in economics.

Positions